Gracell Biotechnologies Inc.

ORBIMED ADVISORS LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

9,308,726

Value ($000)

93,460

Weight

1.9%

2021 Q1 - 2023 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	93,460	1.9%	9,308,726	12/31/2023
2023 Q3	11/14/2023	26,809	0.6%	9,308,726	9/30/2023
2023 Q2	8/14/2023	34,418	0.6%	9,033,726	6/30/2023
2023 Q1	5/15/2023	17,666	0.4%	9,497,774	3/31/2023
2022 Q4	2/14/2023	18,135	0.4%	7,884,870	12/31/2022
2022 Q3	11/14/2022	25,389	0.5%	7,884,870	9/30/2022
2022 Q2	8/15/2022	43,367	0.8%	7,884,870	6/30/2022
2022 Q1	5/16/2022	18,372	0.3%	7,884,870	3/31/2022
2021 Q4	2/14/2022	47,625	0.6%	7,884,870	12/31/2021
2021 Q3	11/15/2021	109,363	1.2%	7,884,870	9/30/2021
2021 Q2	8/16/2021	102,503	1.1%	7,884,870	6/30/2021
2021 Q1	5/17/2021	121,427	1.2%	7,884,870	3/31/2021